EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review

Valentina Prevolnik Rupel (), Marko Divjak, Zsombor Zrubka, Fanni Rencz, László Gulácsi, Dominik Golicki, Dagmara Mirowska-Guzel, Judit Simon, Valentin Brodszky, Petra Baji, Jakub Závada, Guenka Petrova, Alexandru Rotar and Márta Péntek
Additional contact information
Valentina Prevolnik Rupel: Institute for Economic Research
Marko Divjak: DOBA Business School
Zsombor Zrubka: Corvinus University of Budapest
Fanni Rencz: Corvinus University of Budapest
László Gulácsi: Corvinus University of Budapest
Dominik Golicki: Medical University of Warsaw, Poland
Dagmara Mirowska-Guzel: Medical University of Warsaw, Poland
Judit Simon: Medical University of Vienna
Jakub Závada: Institute of Rheumatology
Guenka Petrova: Medical University
Alexandru Rotar: University of Amsterdam
Márta Péntek: Corvinus University of Budapest

The European Journal of Health Economics, 2019, vol. 20, issue 1, No 11, 109-117

Abstract: Abstract Backround Guidelines for economic analyses of health care technologies require local input data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The aim of this study was to systematically review and analyse the available empirical studies using the EQ-5D instrument as a measure of the health-related quality of life (HRQoL) in patients with neurological diseases. Methods A systematic literature search was performed up to 1st April 2018 to identify relevant studies in eight selected CEE countries. Original articles reporting on studies of neurological diseases using the EQ-5D instrument were analysed. Results Thirty-six articles, describing the results of 38 samples of patients and a total of 13,005 patients were included in the review. Most studies were from Hungary (44.4%) and none from Romania or Slovakia. EQ-5D utility scores were reported in 33 (91.7%) articles. In multiple sclerosis (MS) being the most represented disease, the average utility scores ranged from 0.49 in Austria to 0.80 in Poland with a weighted average of 0.69. EQ VAS scores for MS ranged from 39 in Czech Republic to 72.0 in Poland, with weighted average of 59.1. MS patients, together with epilepsy and essential tremor patients, estimated their HRQoL among the highest. Conclusions EQ-5D research activity in neurology has been increasing through the years in studied CEE countries. There are clinical areas with the significant social burden, such as a migraine or meningitis, that are completely lacking data, other areas, such as stroke or epilepsy, with very scarce data.

Keywords: Health-related quality of life; EQ-5D; Neurological diseases; Central and Eastern European countries (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s10198-019-01068-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01068-9

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-019-01068-9

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().